Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,864 | 12,130 | 13,048 | 6,461 | 6,973 |
| Receivables | N/A | N/A | N/A | 883 | N/A |
| Other current assets | 44 | 14 | 21 | 21 | 27 |
| TOTAL | $11,392 | $14,138 | $13,722 | $8,659 | $7,388 |
| Non-Current Assets | |||||
| PPE Net | 3 | 4 | 5 | 6 | 3 |
| Other Non-Current Assets | 474 | 366 | 22 | 36 | 18 |
| TOTAL | $478 | $370 | $27 | $42 | $21 |
| Total Assets | $11,869 | $14,508 | $13,749 | $8,701 | $7,409 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,928 | 1,261 | 2,569 | 2,198 | 4,026 |
| TOTAL | $1,959 | $1,383 | $2,779 | $2,524 | $4,057 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,959 | $1,383 | $2,779 | $2,524 | $4,057 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 620 | 575 | 455 | 245 | 96 |
| Common Shares | 1 | 1 | 3 | 0 | 33 |
| Retained earnings | -94,320 | -91,101 | -88,726 | -84,425 | -81,248 |
| TOTAL | $9,910 | $13,125 | $10,970 | $6,177 | $3,352 |
| Total Liabilities And Equity | $11,869 | $14,508 | $13,749 | $8,701 | $7,409 |